Healthcare
It was a busy week for clinical trial announcements. Here’s a look.
Circulating Tumor Cells (CTC) analysis has great potential to transform the cancer diagnostic landscape
Oncoceutics, Inc. announced that results from the second and third cohort of the Phase II trial for patients with recurrent glioblastoma treated with the company’s lead imipridone, ONC201, were recently published in the journal Neuro-Oncology.
26 relapsed/refractory EBV+ PTLD patients were treated in a multicenter tab-cel® EAP study including a subgroup of 22 patients who would have likely met eligibility criteria for Atara’s ongoing tab‑cel® Phase 3 studies
evitria AG, a global antibody expression service provider, announces the opening of its new head office in Denmark to better serve the growing demand from Scandinavian enterprises.
Reston Hospital Center Nationally Recognized With An ‘A’ Hospital Safety Grade by The Leapfrog Group
Reston Hospital Center was awarded an ‘A’ Leapfrog Hospital Safety Grade for fall 2019, a national distinction recognizing Reston’s achievements in protecting patients from harm and providing safer health care..
The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company.
Completion of public offering and listing of American Depository Shares (ADSs) on Nasdaq Global Select Market under the symbol “GMAB.” Total gross proceeds from the issuance of new shares amounted to USD 582 million (DKK 3,873 million) with a corresponding increase in share capital of 3,277,500 ordinary shares or 32,775,000 ADSs
Presentation at SITC Shows Potential to Flag Solid Tumours as a Target for the Immune System to Attack Using the Company’s DCOne® Cell Vaccine Loaded with a Foreign Antigen
Through the use of cutting-edge gene sequencing, a team of researchers from Abbott Laboratories discovered a new strain of HIV, the first time a new subtype of HIV-1 has been identified in nearly 20 years.
PRESS RELEASES